Inverse Modulation of Il-10 and Il-12 in the Blood of Women with Preneoplastic Lesions of the Uterine Cervix

[en] It has been postulated that an impaired immune response may contribute to the progression of human papillomavirus (HPV)-associated preneoplastic lesions. Based on this hypothesis, we evaluated the cytokine production in the blood of patients with squamous intraepithelial lesions (SIL) of the uterine cervix. The levels of type-1 (interferon-gamma (IFN-gamma) and IL-12) and type-2(IL-4 and IL-10) cytokines were measured in whole blood culture supernatants of patients with low- and high-grade SIL and control women. There was no difference in IL-4 and IFN-gamma levels between patients with SIL and the control group. In contrast, the ratio of IL-12/IL-10 levels was significantly lower in patients with SIL compared with the control group. A lower IL-12/IL-10 ratio in women with SIL was also observed when peripheral blood mononuclear cell (PBMC) culture supernatants and plasma samples were analysed. In patients, neither the lower expression of the CD3epsilon chain nor the higher frequency of HLA-DRB1*1501 expression could be correlated with abnormal cytokine production. These results suggest that a part of the cytokine network, namely IL-10 and IL-12, is perturbed in patients with SIL. A better knowledge of the role of these cytokines in regulating the growth of HPV-associated SIL might have practical implications for the development of vaccines or immunomodulatory strategies in the treatment of cervical cancers.

Disciplines :

Oncology
Immunology & infectious disease

Author, co-author :

Jacobs, Nathalie ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques

Giannini, Sandra L

Doyen, Jean ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique CHR

Baptista, A.

Moutschen, Michel ; Université de Liège - ULiège > Département des sciences cliniques > Immunopathologie - Transplantation

Boniver, Jacques ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques

Delvenne, Philippe ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques

Language :

English

Title :

Inverse Modulation of Il-10 and Il-12 in the Blood of Women with Preneoplastic Lesions of the Uterine Cervix

Publication date :

January 1998

Journal title :

Clinical and Experimental Immunology

ISSN :

0009-9104

eISSN :

1365-2249

Publisher :

Blackwell, Oxford, United Kingdom

Volume :

111

Issue :

Pages :

219-24

Peer reviewed :

Peer Reviewed verified by ORBi

Funders :

F.R.S.-FNRS - Fonds de la Recherche Scientifique
CAC - Centre anticancéreux près l'Université de Liège asbl
Centre de recherche interuniversitaire en vaccinologie (région Wallonne et GSK)

Available on ORBi :

since 11 August 2009

Statistics

Number of views

92 (4 by ULiège)

Number of downloads

2 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Wu T-C, Kurman RJ. Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms. J Natl Cancer Inst 1997; 89:185-7.
NCI Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 1989; 262:931-4.
Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87:796-802.
Benton C, Shahidullah H, Hunter JAA. Human papillomavirus in the immunosuppressed. Papillomavirus Rep 1992; 3:23-26.
Petry KU, Scheffel D, Bode U et al. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer 1994; 57:836-40.
Wu TC. Immunology of the human papilloma virus in relation to cancer. Curr Opin Immunol 1994; 6:746-54.
Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1,Th2 and more. Immunol Today 1996; 17:138-46.
Scott P. IL-12: initiation cytokine for cell-mediated immunity. Sciences 1993; 260:496-7.
Pisa P, Halapi E, Pisa EK et al. Selective expression of interleukin 10, interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 1992; 89:7708-12.
Clerici M, Ferrario E, Trabattoni D et al. Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease. Eur J Cancer 1994; 30A:1464-70.
Huang M, Wang J, Lee P et al. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res 1995; 55:3847-53.
Huettner C, Paulus W, Roggendorf W. Messenger RNA expression of the immunosuppressive cytokine Il-10 in human gliomas. Am J Pathol 1995; 146:317-22.
Krüger-Krasagakes S, Krasagakis K, Garbe C et al. Expression of interleukin 10 in human melanoma. Br J Cancer 1994; 70:1182-5.
Levy S, Kopersztych S, Musatti CC, Souen JS, Salvatore CA, Mendes NF. Cellular immunity in squamous cell carcinoma of the uterine cervix. Am J Obstet Gynecol 1978; 130:160-4.
Kono K, Ressing ME, Brandt RMP et al. Decreased expression of signal-transducing ζ chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res 1996; 2:1825-8.
Elsässer-Beile U, von Kleist S, Sauther W, Gallati H, Schulte Mönting J. Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages. Br J Cancer 1993; 68:32-36.
Clerici M, Merola M, Ferrario E et al. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 1997; 89:245-50.
Davies DH, Stauss HJ. The significance of human leukocyte antigen associations with cervical cancer. Papillomavirus Report 1997; 8:43-50.
Ashton-Rickardt PG, Bandeira A, Delaney JR et al. Evidence for differential avidity model of T cell selection in the thymus. Cell 1994; 76:651-63.
Jacobs MV, De Rodo Husman AM, Van den Bruck AJC, Snijders PJF, Meijer CJLM, Walboomer JMM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995; 33:901-5.
De Groote D, Zangerle PF, Gevaert Y et al. Direct stimulation of cytokines (IL-1β,TNF-α, IL-6, IL-2, IFN-γ, and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992; 4:239-48.
Terstappen LWMM, Buescher S, Nguyen M, Reading C. Differentiation and maturation of growth factor expanded human hematopoietic progenitors assessed by multidimensional flow cytometry. Leukemia 1992; 6:1001-10.
Jacobs N, Moutschen MP, Boniver J, Greimers R, Schaaf-Lafontaine N. Efficient immunoselection of cytolytic effectors with a magnetic cell sorter. Res Immunol 1993; 144:141-50.
Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A,-B,-C and -D antigens. Am J Clin Pathol 1978; 69:103-20.
Buyse I, Decorte R, Cuppens H et al. Rapid DNA typing of class II HLA antigen using polymerase chain reaction and reverse dot blot hybidization. Tissue Antigens 1993; 41:1-14.
Baur MP. Histocompatibility testing. Berlin: Springer-Verlag, 1984.
Koch F, Stanzl U, Jennewein P et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 1996; 184:741-6.
Nakagomi H, Pisa P, Pisa EK et al. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int J Cancer 1995; 63:366-71.
Huang M, Sharma S, Mao JT, Dubinett SM. Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J Immunol 1996; 157:5512-20.
Kim J, Moldin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff BJ, Uyemura K. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol 1995; 155:2240-7.
Kuge S, Watanabe K, Makino K et al. Interleukin-12 augments the generation of autologous tumor-reactive CD8+ cytotoxic T lymphocytes from tumor-infiltrating lymphocytes. Jpn J Cancer Res 1995; 86:135-9.
Tahara H, Zeh IIIHJ, Storkus WJ et al. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res 1994; 54:182-9.
Yu W-G, Yamamoto N, Takenaka H et al. Molecular mechanisms underlying IFN-γ-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12. Int Immunol 1996; 8:855-65.
Chehimi J, Starr SE, Frank I et al. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994; 179:1361-6.
Orange JS, Wang B, Terhost C, Biron CA. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 1996; 156:1138-42.
Viscidi RP, Kotloff KL, Clayman B, Russ K, Shapiro S, Shah KV. Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among College women. Clin Diagn Lab Immunol 1997; 4:122-6.
Tsuki T, Hildesheim A, Schiffman MH et al. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res 1996; 56:3967-74.
McKee WD, Arnold CA, Perlman MD. A double-blind study of comparative incidence of malignancy and allergy. J Allergy 1967; 39:294-301.
Vandenvelde C, De Foor M, Van Beers D. HLA-DQB1*03 and cervical intraepithelial neoplasia grades I-III. Lancet 1993; 341:442-3.
Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genet 1994; 6:157-62.
Gregoire L, Lawrence WD, Kukuruga D, Eisenbrey AB, Lancaster WB. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int J Cancer 1994; 57:504-7.
Sastre-Garau X, Loste M-N, Vincent-Salomon A et al. Decreased frequency of HLA-DRB1*13 alleles in French women with HPV-positive carcinoma of the cervix. Int J Cancer 1996; 69:159-64.
Woodworth CD, Simpson S. Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines. Am J Pathol 1993; 56:3967-74.
Malejczyk J, Malejczyk M, Urbanski A et al. Constitutive release of IL6 by human papillomavirus type 16 (HPV16)-harboring keratinocytes: a mechanism augmenting the NK-cell-mediated lysis of HPV-bearing neoplastic cells. Cell Immunol 1991; 136:155-64.
Tatour E, Gey A, Sastre-Garau X et al. Analysis of interleukin 6 expression in cervical neoplasia using a quantative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma. Cancer Res 1994; 54:6243-8.